PEREGRINE CAPITAL MANAGEMENT LLC

Position in COLL — Collegium Pharmaceutical, Inc

CIK 764529 MINNEAPOLIS, MN

Back to COLL Full portfolio

Position in COLL

as of Jun 30, 2026 · filed Jul 17, 2026 Compact

Position Value

$4,684,859

+$1,500,020 QoQ

Shares Held

129,416

+34.4% QoQ

Ownership

0.398%

of shares outstanding

% of Portfolio

0.16%

of 13F equity value

Holder Rank

#43

of 279 holders

Holding Since

Sep 2021

12 quarters on record

Voting authority Sole 62% Shared 0% None 38%

Common Shares in COLL Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

PEREGRINE CAPITAL MANAGEMENT LLC holds $27,179,481 across 3 Drug Manufacturers - Specialty & Generic names. COLL ranks #3 (17.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALKS	Alkermes plc.	232,255	$12,169,000
2	KNSA	Kiniksa Pharmaceuticals International, plc	161,464	$10,325,622
3	COLL	Collegium Pharmaceutical, Inc This page	129,416	$4,684,859

All Filings in COLL

Export CSV

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,684,859	129,416	+34.4%	Shares	Sole	2026-07-17
2026-03-31	$3,184,839	96,306	-72.0%	Shares	Sole	2026-04-23
2023-12-31	$10,604,694	344,532	-25.0%	Shares	Sole	2024-01-26
2023-09-30	$10,262,896	459,190	-4.1%	Shares	Sole	2023-10-19
2023-06-30	$10,289,970	478,826	-4.0%	Shares	Sole	2023-07-26
2023-03-31	$11,962,565	498,648	-7.9%	Shares	Sole	2023-04-26
2022-12-31	$12,560,294	541,392	-1.1%	Shares	Sole	2023-01-10
2022-09-30	$8,767,441	547,281	-0.3%	Shares	Sole	2022-10-26
2022-06-30	$9,723,991	548,758	-1.4%	Shares	Sole	2022-07-20
2022-03-31	$11,333,556	556,658	-3.3%	Shares	Sole	2022-04-27
2021-12-31	$10,757,793	575,899	-15.6%	Shares	Sole	2022-01-31
2021-09-30	$13,463,943	682,064	—	Shares	Sole	2021-11-02
No filing history on record for this holder in this stock.